1-19308193-T-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_003689.4(AKR7A2):c.556A>C(p.Lys186Gln) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003689.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AKR7A2 | NM_003689.4 | c.556A>C | p.Lys186Gln | missense_variant | Exon 3 of 7 | ENST00000235835.8 | NP_003680.2 | |
AKR7A2 | XM_047433095.1 | c.556A>C | p.Lys186Gln | missense_variant | Exon 3 of 4 | XP_047289051.1 | ||
AKR7A2 | NM_001320979.1 | c.486+262A>C | intron_variant | Intron 2 of 5 | NP_001307908.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.556A>C (p.K186Q) alteration is located in exon 3 (coding exon 3) of the AKR7A2 gene. This alteration results from a A to C substitution at nucleotide position 556, causing the lysine (K) at amino acid position 186 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.